Page 4,700«..1020..4,6994,7004,7014,702..4,7104,720..»

Leisure centre's plea for donors after colleague diagnosed with leukaemia

Posted: Published on January 12th, 2014

Fareham Leisure Centre holding bone marrow donor day after colleague Chris Spencer diagnosed with leukaemia 4:00pm Saturday 11th January 2014 in News By Julian Robinson, Eastleigh Chief Reporter STAFF at a Hampshire leisure centre are holding a stem cell recruitment day to support one of their colleagues. Workers at Fareham Leisure centre want potentially life-saving bone marrow donors to drop in on Wednesday. The initiative comes after one of their colleagues, Chris Spencer, recently underwent a bone marrow transplant through the Anthony Nolan stem cell charity after being diagnosed with leukaemia in June 2013. Participants need to be aged between 16 and 30 and be in good health to become a donor. General manager Ryan Grant said: Were thrilled to be hosting a recruitment day to raise awareness and help support Anthony Nolans invaluable work. For thousands of people with blood cancers such as leukaemia, their only hope of survival is a donation of healthy stem cells. Were giving the public the opportunity to see whether theyre a match. The event runs from 4.30pm to 8pm at Fareham Leisure Centre. Call 01329 233652 for more information. See the rest here: Leisure centre's plea for donors after colleague diagnosed with leukaemia … Continue reading

Posted in Stem Cell Transplant | Comments Off on Leisure centre's plea for donors after colleague diagnosed with leukaemia

lateral canthus reconstruction how to find the lateral canthus ligament – Video

Posted: Published on January 12th, 2014

lateral canthus reconstruction how to find the lateral canthus ligament This video contains the actual surgery footage of lateral canthus reconstruction with detailed explanations of the process and method at Aone Plastic and Aes... By: … Continue reading

Posted in Aesthetic Surgery | Comments Off on lateral canthus reconstruction how to find the lateral canthus ligament – Video

Biotech Stock Mailbag: NeoStem, MannKind, Inovio

Posted: Published on January 12th, 2014

Welcome to this week's Biotech Stock Mailbag. Before I kick off, a few housekeeping items to note: I launched a new blog on TheStreet this week. It's called Adam's Biotech Beat. I know, not the most original name but straightforward. I'll have more to say about the blog later, but please bookmark the page and check it often. You'll see me posting a lot of intraday news and analysis, plus it's a great way to keep track of all my tweets. The J.P. Morgan Healthcare Conference starts Monday in San Francisco. I'm flying out there Sunday and will be providing live coverage from the presentations and breakout rooms. Chelsea Therapeutics (CHTP) and its hypotension drug Northera will be the star of an FDA advisory panel on Tuesday. I have invited healthcare investor and TheStreet contributing writer Aafia Chaudhry to live-blog the Chelsea panel, so please tune into that. More: Biotech Stock Mailbag: NeoStem, MannKind, Inovio … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Biotech Stock Mailbag: NeoStem, MannKind, Inovio

Artificial bone marrow development brings leukemia treatment closer to reality

Posted: Published on January 12th, 2014

Washington, Jan. 11 : Researchers have developed a prototype of artificial bone marrow that may be used to reproduce hematopoietic stem cells. The porous structure developed by the scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tubingen University, possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells at the laboratory. This might facilitate the treatment of leukemia in a few years. Blood cells, such as erythrocytes or immune cells, are continuously replaced by new ones supplied by hematopoietic stem cells located in a specialized niche of the bone marrow. Hematopoietic stem cells can be used for the treatment of blood diseases, such as leukemia. The affected cells of the patient are replaced by healthy hematopoietic stem cells of an eligible donor. However, not every leukemia patient can be treated in this way, as the number of appropriate transplants is not sufficient. This problem might be solved by the reproduction of hematopoietic stem cells. The stem cell niche is a complex microscopic environment having specific properties. The relevant areas in the bone are highly porous and similar to a sponge. This three-dimensional environment does not only accommodate bone cells … Continue reading

Comments Off on Artificial bone marrow development brings leukemia treatment closer to reality

Devoting a career to autism treatment and research

Posted: Published on January 11th, 2014

DURHAM When Geri Dawson was in graduate school for clinical psychology, her first patient had a perplexing disorder that kept him from learning how to relate to others the way most children do. It was 1979, and autism was so rare that her team flew in specialists from across the country. Dawson was so intrigued by the utter lack of knowledge about autism and heartbroken by the impact it had on her patients family that she embarked on a career devoted to studying and treating the disorder. We had absolutely no idea how a child could come into this world and not be able to form social relationships with other people, she says. We also had very little to offer this family. Dawson, 62, became one of the countrys foremost autism researchers during a three-decade span in which the disorder grew more frequently diagnosed and better understood. As recently as 1994, only an estimated one in 1,500 U.S. children had been diagnosed with what is now called autism spectrum disorder. Now, one in 88 children has it, according to estimates by the Centers for Disease Control and Prevention. Early in Dawsons career, she pioneered detection and intervention methods for young … Continue reading

Comments Off on Devoting a career to autism treatment and research

Complementary medicine widely used to treat children with autism, developmental delay

Posted: Published on January 11th, 2014

Jan. 11, 2014 In a study of the range of treatments being employed for young children with autism and other developmental delays, UC Davis MIND Institute researchers have found that families often use complementary and alternative medicine (CAM) treatments and that the most frequent users of both conventional and complementary approaches are those with higher levels of parental education and income. There is no Food and Drug Administration-approved medical treatment for the core symptoms of autism spectrum disorder, a lifelong neurodevelopmental condition whose hallmarks are deficits in social relatedness, repetitive thoughts and behaviors and, often, intellectual disability. In the search for treatments to help their children, families may turn to unconventional approaches such as mind-body medicine (e.g. meditation or prayer), homeopathic remedies, probiotics, alternative diets or more invasive therapies such as vitamin B-12 injections, intravenous immunoglobulin or chelation therapy -- some of which carry significant risks. The research is published online today in the Journal of Behavioral and Developmental Pediatrics. It was led by Robin Hansen, director of the Center for Excellence in Developmental Disabilities at the MIND Institute and chief of the Division of Developmental Behavioral Pediatrics in the UC Davis School of Medicine. "In our Northern California study … Continue reading

Comments Off on Complementary medicine widely used to treat children with autism, developmental delay

UC Davis Finds that Complementary Medicine is Widely Used to Treat Children with Autism

Posted: Published on January 11th, 2014

Sacramento, CA (PRWEB) January 11, 2014 In a study of the range of treatments being employed for young children with autism and other developmental delays, UC Davis MIND Institute researchers have found that families often use complementary and alternative medicine (CAM) treatments and that the most frequent users of both conventional and complementary approaches are those with higher levels of parental education and income. There is no Food and Drug Administration-approved medical treatment for the core symptoms of autism spectrum disorder, a lifelong neurodevelopmental condition whose hallmarks are deficits in social relatedness, repetitive thoughts and behaviors and, often, intellectual disability. In the search for treatments to help their children, families may turn to unconventional approaches such as mind-body medicine (e.g. meditation or prayer), homeopathic remedies, probiotics, alternative diets or more invasive therapies such as vitamin B-12 injections, intravenous immunoglobulin or chelation therapy some of which carry significant risks. The research is published online today in the Journal of Behavioral and Developmental Pediatrics. It was led by Robin Hansen, director of the Center for Excellence in Developmental Disabilities at the MIND Institute and chief of the Division of Developmental Behavioral Pediatrics in the UC Davis School of Medicine. In our Northern … Continue reading

Comments Off on UC Davis Finds that Complementary Medicine is Widely Used to Treat Children with Autism

How an iPad can prevent critical stroke injury

Posted: Published on January 11th, 2014

WASHINGTON -- "Time is brain" when it comes to a person who is suffering a stroke. In fact, time is a stroke victim's greatest enemy. The faster they get treatment, the better the outcome. So says one stroke neurologist with the University of Virginia Health System, which is working with local rescue squads to outfit ambulances with iPads and tablets, so that doctors can diagnose such patients en route to the hospital. Stroke is the leading cause of long-term adult disability in the U.S., says Dr. Andrew Southerland, a stroke neurologist with the University of Virginia Health System, which is raising $10,000 to get new mobile iTREAT telemedicine kits online. Dr. Southerland tells WTOP that the longest delay in treating stroke patients doesn't happen once they get to the hospital, but before they get there. That's where the iTREAT kits would come in. Rescue workers can diagnose a stroke patient right in the back of the ambulance, using the hand-held technology to connect via video with doctors. "That's otherwise idle travel time that we could begin the diagnostic and treatment process," Southerland says. That's important, considering that only five percent of stroke patients ever receive the clot-busting drug otherwise known … Continue reading

Comments Off on How an iPad can prevent critical stroke injury

Calgary medical team attempting stem cell therapy on paralyzed man

Posted: Published on January 11th, 2014

Ryan White, CTV Calgary Published Friday, January 10, 2014 3:37PM MST Last Updated Friday, January 10, 2014 7:10PM MST Alex Petric is hoping his part in an international clinical trial at the Foothills Hospital will assist researchers in the development of a treatment for spinal cord injuries. Alex, a paramedic from Winnipeg, was paralyzed during a winter holiday in Panama with his girlfriend. The 28-year-old dove headfirst into what he believed to be deep water. Immediately I felt paralyzed, right when I came up, recollects Alex. You just know youre in a lot of trouble. Youre trying your hardest to move your legs and its not happening. Ten months after the accident, 29-year-old Alex is taking part in a medical trial to determine the safety of stem cell therapy on patients with spinal cord injuries. While the trial, conducted by researchers from the University of Calgary, focuses on safety, the ultimate goal is to develop a cure for spinal cord injuries which could require multiple therapies. The medical team, led by Dr. Steve Casha, will make a small incision in order to view Alexs injury. Once the precise location of the injury has been determined, then stem cells are injected … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Calgary medical team attempting stem cell therapy on paralyzed man

Gene therapy may hold promise for advanced Parkinson’s disease

Posted: Published on January 11th, 2014

By Steven Reinberg HealthDay Reporter THURSDAY, Jan. 9, 2014 (HealthDay News) -- A new, preliminary treatment involving triple-gene therapy appears safe and effective in helping to control motor function in Parkinson's disease patients, according to new research. The therapy, called ProSavin, works by reprogramming brain cells to produce dopamine, the chemical essential for controlling movement, the researchers said. Lack of dopamine causes the tremors, limb stiffness and loss of balance that patients with the neurodegenerative disease suffer. "We demonstrated that we are able to safely administer genes into the brain of patients and make dopamine, the missing agent in Parkinson's patients," said researcher Kyriacos Mitrophanous, head of research at Oxford BioMedica in England, the company that developed the therapy and funded the study. ProSavin also helps to smooth out the peaks and valleys often produced by the drug levodopa, the current standard treatment, Mitrophanous said. The treatment uses a harmless virus to deliver three dopamine-making genes directly to the area of the brain that controls movement, he explained. These genes are able to convert non-dopamine-producing nerve cells into dopamine-producing cells. Although the study results are promising, the researchers suggest they should be "interpreted with caution" because the perceived benefits fall … Continue reading

Posted in Parkinson's Treatment | Comments Off on Gene therapy may hold promise for advanced Parkinson’s disease

Page 4,700«..1020..4,6994,7004,7014,702..4,7104,720..»